● Goals
Start with the research area
Every plain-language goal below maps to the compounds studied in that area's research literature — with the evidence label attached, never a health claim. Counts and price floors are live from the index.
Metabolic & weight research
The GLP-1 / amylin cluster — the most-studied compounds in the index, and the only area with comparative human-trial figures.
Strong evidence
Longevity & cellular-aging research
NAD+, epithalon, MOTS-c and the cellular-aging literature — mechanisms well mapped, human outcomes mostly not.
Strong evidence
Growth-hormone / IGF-axis research
Secretagogues and IGF-axis compounds studied for growth-hormone release and body-composition endpoints.
Strong evidence
Tissue repair & recovery research
BPC-157, TB-500 and the soft-tissue / wound literature — heavily searched, almost entirely preclinical.
Preclinical only
Skin, hair & pigmentation research
Copper peptides and melanotan — the cosmetic, hair and pigmentation literature.
Preclinical only
Cognitive & neuro research
Semax, selank and DSIP — neuro-peptide research with thin controlled human data.
Limited evidence
Reproductive & sexual-health research
Kisspeptin, PT-141 and melanotan-2 — reproductive and sexual-health studies.
Moderate evidence
Sleep research
DSIP and tesamorelin appear in sleep literature, but neither listing turns investigational evidence into an approved sleep use.
Strong evidence
Immune research
Thymosin alpha-1 — the one immune-literature compound we track, and one of the better-studied.
Strong evidence
All products listed are sold by third-party vendors for laboratory and research use only (RUO). Where an FDA label or a peer-reviewed study has published a dose, pepmg reports it with the source named, because that is safer than guessing. It is a report, not medical advice and not a recommendation to use anything. pepmg sells nothing and ships nothing. Listings are price-tracking data, not endorsements.